Porphyrin synthesis from aminolevulinic acid esters in endothelial cells and its role in photodynamic therapy

Journal of Photochemistry and Photobiology B: Biology

Volumn 96, Issue 3, 2009, Pages 249-254

  Rodriguez, Lorena ^a   de Bruijn, Henriëtte S ^b   Di Venosa, Gabriela ^a   Mamone, Leandro ^a   Robinson, Dominic J ^b   Juarranz, Angeles ^c   Batlle, Alcira ^a   Casas, Adriana ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

ALA esters; Aminolevulinic acid; Endothelial cells; Hexyl ALA; Methyl ALA; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID METHYL ESTER; PROTOPORPHYRIN;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; VASCULARIZATION;

AMINOLEVULINIC ACID; ANIMALS; CELL LINE; ENDOTHELIAL CELLS; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; ULTRAVIOLET RAYS;

EID: 68649108677     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.07.001     Document Type: Article

References (42)

1. Gomer C.J., Ferrario A., Luna M., Rucker N., and Wong S. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Lasers Surg. Med. 38 (2006) 516-521
2. Busch T.M. Local physiological changes during photodynamic therapy. Lasers Surg. Med. 38 (2006) 494-499
3. Chen B., Pogue B.W., Hoopes P.J., and Hasan T. Vascular and cellular targeting for photodynamic therapy. Crit. Rev. Eukar. Gene Expression 16 (2006) 279-305
4. Kennedy J., Pottier R., and Pross G. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B 6 (1990) 143-148
5. Batlle A.M. Porphyrins porphyrias cancer and photodynamic therapy: a model for carcinogenesis. J. Photochem. Photobiol. B 20 (1993) 5-22
6. Peng Q., Moan J., Warloe T., Nesland J.M., and Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int. J. Cancer 52 (1992) 433-443
7. Wyld L., Burn J.L., Reed M.W., and Brown N.J. Factors affecting aminolevulinic acid-induced generation of protoporphyrin IX. Br. J. Cancer 76 (1997) 705-712
8. He D., Behar S., Nomura N., Sassa S., and Lim H.W. The effect of ALA and radiation on porphyrin/heme biosynthesis in endothelial cells. J. Photochem. Photobiol. 61 (1995) 656-661
9. He D., Behar S., Roberts J.E., and Lim H.W. The effect of l-cysteine and N-acetylcysteine on porphyrin/heme biosynthetic pathway in cells treated with 5-aminolevulinic acid and exposed to radiation. Photodermatol. Photoimmunol. Photomed. 12 (1996) 194-199
10. Chang C.J., Sun C.H., Liaw L.H., Berns M.W., and Nelson J.S. In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells. Lasers Surg. Med. 24 (1999) 178-186
11. Peng Q., Warloe T., Moan J., Heyerdahl H., Steen H., Giercksky K., and Nesland J. ALA derivative-induced protoporphyrin IX build-up and distribution in human nodular basal cell carcinoma. Photochem. Photobiol. 61 (1995) abstract 82S
12. Casas A., and Batlle A. Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy. Curr. Med. Chem. 13 (2006) 1157-1168
13. Kloek J., Akkermans W., and Beijersbergen van Henegouwen G.M. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem. Photobiol. 67 (1998) 150-154
14. Casas A., Batlle A.M., Butler A.R., Robertson D., Brown E.H., MacRobert A., and Riley P.A. Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures. Br. J. Cancer 80 (1999) 1525-1532
15. van der Meijden A.P., Sylvester R., Oosterlinck W., Solsona E., Boehle A., Lobel B., and Rintala E. For the EAU working party on non muscle invasive bladder cancer. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur. Urol. 48 (2005) 363-371
16. Fritsch C., Homey B., Stahl W., Lehmann P., Ruzicka T., and Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem. Photobiol. 68 (1998) 218-221
17. Peng Q., Soler A., Warloe T., Nesland J., and Giercksky K.J. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. Photochem. Photobiol. B. 62 (2001) 140-145
18. Gardlo K., and Ruzicka T. Metvix (PhotoCure). Curr. Opin. Invest. Drugs 3 (2002) 1672-1678
19. de Bruijn H.S., Meijers C., van der Ploeg-van den Heuvel A., Sterenborg H.J., and Robinson D.J. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate. J. Photochem. Photobiol. B 92 (2008) 91-97
20. Takeya H. Preparation of 5-aminolevulinic acid alkyl esters as herbicides. Chem. Abstr. 116 (1992) 189633m
21. Ades E.W., Candal F.J., Swerlick R.A., George V.G., Summers S., Bosse D.C., and Lawley T.J. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Vasc. Endoth. Cell Line Dermatol. 99 (1992) 683-690
22. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89 (1986) 271-277
23. Iinuma S., Farshi S.S., Ortel B., and Hasan T. A mechanistic study of cellular photoactivation with 5-aminolevulinic acid-induced porphyrins. Br. J. Cancer 70 (1994) 21-28
24. Casas A., Perotti C., Ortel B., Di Venosa G., Saccoliti M., Batlle A., and Hasan T. Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells. Int. J. Oncol. 29 (2006) 397-405
25. Rodriguez L., Divenosa G., Batlle A., Macrobert A., and Casas A. Response to ALA-based PDT in an immortalised normal breast cell line and its counterpart transformed with the Ras oncogene. Photochem. Photobiol. Sci. 6 (2007) 1306-1310
26. Tunstall R.G., Barnett A.A., Schofield J., Griffiths J., Vernon D.I., Brown S.B., and Roberts D.J. Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo. Br. J. Cancer 87 (2002) 246-250
27. Egli R., Schober M., Hempfing A., Ganz R., Hofstetter W., and Leunig M. Sensitivity of osteoblasts, fibroblasts, bone marrow cells, and dendritic cells to 5-aminolevulinic acid based photodynamic therapy. J. Photochem. Photobiol. B 89 (2007) 70-77
28. Jones H.A., Hahn S.M., Bernhard E., and McKenna W.G. Ras inhibitors and radiation therapy. Semin. Radiat. Oncol. 11 (2001) 328-337
29. Schäfer R., Schramme A., Tchernitsa O.I., and Sers C. Oncogenic signaling pathways and deregulated target genes. Recent Res. Cancer Res. 176 (2007) 7-24
30. Steinbach P., Weingandt H., Baumgartner R., Kriegmair M., Hofstädter F., and Knüchel R. Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid. J. Photochem. Photobiol. 62 (1995) 887-895
31. Spörri S., Chopra V., Egger N., Hawkins H.K., Motamedi M., Dreher E., and Schneider H. Effects of 5-aminolaevulinic acid on human ovarian cancer cells and human vascular endothelial cells in vitro. J. Photochem. Photobiol. B 64 (2001) 8-20
32. Lim H., Behar S., and He D. Effect of porphyrin and irradiation on heme biosynthetic pathway in endothelial cells. Photodermatol. Photoimmunol. Photomed. 10 (1994) 17-21
33. West C.M.L., West D.C., Kumar S., and Moore J.V. A comparison of the sensitivity of photodynamic treatment of endothelial cells and tumour cells in different proliferative states. Int. J. Radiol. Biol. 58 (1990) 145-156
34. Gomer C.J., Rucker N., and Murphee L. Differential cell photosensitivity following porphyrin photodynamic therapy. Cancer Res. 48 (1988) 4539-4552
35. Reed M.W.R., Wieman T.J., Schuschke D.A., Tseng M.T., and Miller F.N. A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. Radiat. Res. 119 (1989) 542-552
36. Casas A., and Batlle A. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Curr. Med. Chem. Anticancer Agents 2 (2002) 465-475
37. Uehlinger P., Zellweger M., Wagnières G., Juillerat-Jeanneret L., van den Bergh H., and Lange N. 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J. Photochem. Photobiol. B 54 (2000) 72-80
38. Wiegell S., and Wulf H. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J. Am. Acad. Dermatol. 54 (2006) 647-651
39. Yung A., Stables G., Fernandez C., Williams J., Bojar R., and Goulden V. Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolevulinate and hexyl aminolevulinate cream. Clin. Exp. Dermatol. 32 (2007) 716-721
40. Marti A., Jichlinski P., Lange N., et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J. Urol. 170 (2003) 428-432
41. Berger Y., Ingrassia L., Neier R., and Juillerat-Jeanneret L. Evaluation of dipeptide-derivatives of 5-aminolevulinic acid as precursors for photosensitizers in photodynamic therapy. Bioorg. Med. Chem. 11 (2003) 1343-1351
42. Vallinayagam R., Schmitt F., Barge J., Wagnieres G., Wenger V., Neier R., and Juillerat-Jeanneret L. Glycoside esters of 5-aminolevulinic acid for photodynamic therapy of cancer. Bioconjug. Chem. 19 (2008) 821-839